Neurocrine Biosciences In... (NBIX)
NASDAQ: NBIX
· Real-Time Price · USD
120.19
1.07 (0.90%)
At close: May 23, 2025, 3:59 PM
119.31
-0.73%
After-hours: May 23, 2025, 07:18 PM EDT
0.90% (1D)
| Bid | 115.26 |
| Market Cap | 11.89B |
| Revenue (ttm) | 2.41B |
| Net Income (ttm) | 305.8M |
| EPS (ttm) | 2.95 |
| PE Ratio (ttm) | 40.74 |
| Forward PE | 20 |
| Analyst | Buy |
| Ask | 124.9 |
| Volume | 703,892 |
| Avg. Volume (20D) | 1,545,726 |
| Open | 118.05 |
| Previous Close | 119.12 |
| Day's Range | 117.84 - 120.30 |
| 52-Week Range | 84.23 - 157.98 |
| Beta | 0.26 |
About NBIX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBIX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBIX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 weeks ago
+8.36%
Neurocrine Biosciences shares are trading higher a...
Unlock content with
Pro Subscription
3 months ago
+3.94%
Neurocrine Biosciences shares are trading higher after the company authorized a $500 million share repurchase program.
2 weeks ago · seekingalpha.com
Neurocrine Biosciences, Inc. (NBIX) Q1 2025 Earnings Call TranscriptNeurocrine Biosciences, Inc. (NASDAQ:NBIX ) Q1 2025 Results Conference Call May 5, 2025 4:30 PM ET Company Participants Todd Tushla - Vice President of Investor Relations Kyle Gano - Chief Executive O...
